MedPath

To Study The Effect Of Tilvak Ghrita Uttarbasti And Matrabasti In The Management Of Mootraghata (Benign Prostatic Hyperplasia)

Phase 2
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2021/04/032967
Lead Sponsor
Government Akhandanand Ayurved College Ahmedabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients presenting with classical signs and symptoms of Benign Prostatic Hyperplasia

Controlled case of Diabetes mellitus (RBS upto 180 mg/dl) and Hypertension (upto 150/90 mmHg)

Exclusion Criteria

CA Prostate

Urethral stricture

Benign tumour of urethra

Malignant tumour of urethra

Urethral injury Urethral calculi

Age above 80 years and below 40 years

Patients with systemic diseases like uncontrolled Hypertension (more than 150/90 mmHg) and Uncontrolled Diabetes mellitus (RBS more than 180 mg/dl) Tuberculosis STD HIV HBsAg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Result will be assased on the basis of relief sign and symptoms of MootraghataTimepoint: 21 Days
Secondary Outcome Measures
NameTimeMethod
Comparing the effect of both procedures in the management of MootraghataTimepoint: 21 Days
© Copyright 2025. All Rights Reserved by MedPath